New pill takes on hard-to-treat cancers in early trial
Disease control
Not yet recruiting
This early-phase study tests a new drug called IN10028 in 75 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors when used alone or with other cancer m…
Phase: PHASE1 • Sponsor: InxMed (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC